Sources

“What Are the Possible Benefits and Risks of Clinical Trials?” National Institutes of Health, U.S. Department of Health and Human Services

“Anaplastic Large Cell Lymphoma - Lymphoma Research Foundation.” Anaplastic Large Cell Lymphoma - Lymphoma Research Foundation

“Lymphoma Research Foundation .” Anaplastic Large Cell Lymphoma - Lymphoma Research Foundation, Lymphoma Research Foundation

Department of Health & Human Services. “ALK gene - Genetics Home Reference.” U.S. National Library of Medicine, National Institutes of Health

U.S. Department of Health and Human Services. “Lymphoma.” National Cancer Institute

Surveillance Research Program. “Surveillance, Epidemiology, and End Results Program.” Non-Hodgkin Lymphoma - Cancer Stat Facts, U.S. Department of Health and Human Services

Vose, Julie M. “Anaplastic Large Cell Lymphoma.” Anaplastic Large Cell Lymphoma - Lymphoma Research Foundation, 2009

“Anaplastic large cell lymphoma (ALCL).” Leukaemia Foundation, Leukaemia Foundation Australia

“Anaplastic large cell lymphoma (ALCL).” Leukaemia, Lymphoma, Myeloma & Related Blood Disorders., Leukaemia Foundation Australia

U.S. Department of Health and Human Services. “Anaplastic Large Cell Lymphoma (ALCL) In Women with Breast Implants: Preliminary FDA Findings and Analyses.” Anaplastic Large Cell Lymphoma (ALCL) In Women with Breast Implants: Preliminary FDA Findings and Analyses, Jan. 2011

“Anaplastic Large Cell Lymphoma (ALCL) In Women with Breast Implants: Preliminary FDA Findings and Analyses .” Center for Devices and Radiological Health U.S. Food and Drug Administration , Health U.S. Food and Drug Administration